Tag: Trufill n-BCA
Procedural choices matter but vascular penetration has minimal impact on MMAe...
Sub-analyses of two randomised controlled trials (RCTs) have found that, while the extent of vascular penetration appears to have a minimal bearing on outcomes,...
TRUFILL n-BCA is a “critical tool” in any neurointerventional armamentarium
NOTE: This video is ONLY available to watch in selected countries and geographies
With a list of benefits including customisability, high radiopacity and shortened...
MEMBRANE becomes latest RCT to demonstrate MMA embolisation’s benefits in cSDH...
The MEMBRANE randomised controlled trial (RCT)—presented at the 2024 Society of Vascular and Interventional Neurology (SVIN) annual meeting (20–22 November, San Diego, USA) by...
